Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Aptose Biosciences, Inc. (APTOF) had Income from Continuous Operations of $-1.58M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-1.58M |
|
-- |
|
-- |
|
$2.19M |
|
$-2.19M |
|
$0.60M |
|
$-1.58M |
|
$-1.58M |
|
$-1.58M |
|
|
Income from Continuous Operations |
$-1.58M |
$-1.58M |
|
$-1.58M |
|
$-2.19M |
|
$-2.09M |
|
0.70M |
|
0.70M |
|
$9.57 |
|
$9.57 |
|
| Balance Sheet Financials | |
$9.53M |
|
$0.03M |
|
$0.60M |
|
$10.13M |
|
$4.46M |
|
$10.02M |
|
$10.21M |
|
$14.67M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
2.01M |
|
| Cash Flow Statement Financials | |
$-35.98M |
|
$0.02M |
|
$33.41M |
|
$9.25M |
|
$6.71M |
|
$-2.54M |
|
$1.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.14 |
|
-- |
|
-- |
|
1.83 |
|
-2.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-35.96M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
34.89% |
|
34.89% |
|
-15.65% |
|
-28.95% |
|
$-2.26 |
|
$-51.45 |
|
$-51.47 |
|